Retinoids (Q41603250)

4 October 2017

1 reference

title

Retinoids (English)

1 reference

4 October 2017

Gollnick HP

1

1 reference

4 October 2017

Dümmler U

series ordinal

2

1 reference

4 October 2017

publication date

1 September 1997

1 reference

4 October 2017

published in

Clinics in Dermatology

1 reference

4 October 2017

volume

15

1 reference

4 October 2017

issue

5

1 reference

4 October 2017

page(s)

799-810

1 reference

The retinoids. A review of their clinical pharmacology and therapeutic use.

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Oral retinoids--efficacy and toxicity in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Chemotherapy of psoriasis and other skin disorders with oral retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liarozole.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Identification of a second human retinoic acid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Polarity-specific activities of retinoic acid receptors determined by a co-repressor.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Transfer of retinoic acid from its complex with cellular retinoic acid-binding protein to the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Human skin retinoid-binding proteins and therapy with synthetic retinoids: a still unexplained link

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

A new retinoic acid receptor identified from a hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

A human retinoic acid receptor which belongs to the family of nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Specificity in the synergism between retinoic acid and EGF on the growth of adult human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Cultivation of human dermal microvascular endothelial cells in vitro: Immunocytochemical and ultrastructural characterization and effect of treatment with three synthetic retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Proliferation and glycosaminoglycans secretion in fibroblasts from psoriatic skin: differential responses to retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Synthetic retinoids inhibit the antigen presenting properties of epidermal cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Beneficial effect of a combination of retinoids and long-acting theophylline in the treatment of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Retinoid Therapy for Acute Promyelocytic Leukemia: A Coming of Age for the Differentiation Therapy of Malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

The metabolism of acitretin and isoacitretin in the in situ isolated perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Acitretin. A review of its pharmacology and therapeutic use

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate*

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

[Trans-acitretin is metabolized back to etretinate. Importance for oral retinoid therapy]

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Etretinate therapy reduces inpatient treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Oral psoriasis treatment with a new aromatic retinoid (Ro 10-9359): a multi-centre controlled study of 291 patients (preliminary results) (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Photochemotherapy for severe psoriasis without or in combination with acitretin: A randomized, double-blind comparison study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Treatment of psoriasis by oral PUVA therapy combined with aromatic retinoid (Ro 10-9359; Tigason)

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Effect of etretinate on cyclosporin metabolism in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Benefit of progressively increasing doses during the initial treatment with acitretin in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Side-effect profile of acitretin therapy in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin)

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900013-8

7 January 2021

10.1016/S0738-081X(97)00013-8

Identifiers

DOI

1 reference

4 October 2017

1 reference